2-amino-5-cyano-1,4-dihydropyridines, and their use in medicamen

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D40104, A61K 3144

Patent

active

052255581

ABSTRACT:
The present invention relates to new 2-amino-5-cyano-4-quinoline-1,4-dihydropyridines, processes for their preparation and their use in medicaments, in particular in agents for the treatment of cardiovascular diseases.

REFERENCES:
patent: 2359329 (1944-10-01), Phillips et al.
patent: 3862162 (1975-01-01), Meyer et al.
patent: 3996234 (1976-12-01), Bossert et al.
patent: 4001250 (1977-01-01), Lantzsch et al.
patent: 4001258 (1977-01-01), Meyer et al.
patent: 4532248 (1985-07-01), Franckowiak et al.
patent: 5100900 (1992-03-01), Stoltefuss et al.
Journal of the Chemical Society, 1946, pp. 884-888.
Liebigs Ann. Chem. 1977, 1895-1908.
J. Heterocyclic Chem., 26, 1575 (1989).
Chem. Pharm. Bull., vol. 20, No. 10, pp. 2123-2127 (1972).
"Neuartige Kondensationsreaktionen . . . ", C. H. Eugster et al, volumen XLVI, Fasciculus II (1963)-No. 56057.
J. Physiol. (1965), 180, pp. 529-541.
J. Heterocyclic Chemistry, vol. 6, No. 2, Apr. 1969, pp. 243-245.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-amino-5-cyano-1,4-dihydropyridines, and their use in medicamen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-amino-5-cyano-1,4-dihydropyridines, and their use in medicamen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-amino-5-cyano-1,4-dihydropyridines, and their use in medicamen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1691054

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.